Abstract:Background: High fasting plasma glucose (HFPG) is the fastest-growing risk factor for cancer deaths worldwide. We reported the cancer burden attributed to HFPG in a total of 204 countries and territories over the past three decades and associations with age, period, and birth cohort. Furthermore, we investigated the association between glycemic levels and all-cause mortality in cancer survivors.Methods: The estimated data on cancer burden attributable to HFPG were retrieved from the Global Burden of Disease Study 2019. The net drift, as well as the effects of age, period, and birth cohort, were assessed by the age-period-cohort model. Data for the association between glycemic levels and mortality were obtained from the 1999-2018 National Health and Nutrition Examination Survey (NHANES). Cox proportional hazard and restricted cubic spline regression models were performed to evaluate the associations between haemoglobin A1c (HbA1c) and all-cause mortality in cancer survivors.Findings: Over the past 30 years, the global age-standardized mortality rate (ASMR) attributable to HFPG has been increased by 27.8%. The ASMR in 2019 was highest in the male population in high sociodemographic index (SDI) areas (8.70; 95% CI, 2.23-18.04). The net drift for mortality was highest in the female population in low SDI areas (2.33; 95% CI, 2.21-2.44). Unfavorable period and cohort effects were found across most countries. The trend of disability-adjusted life years (DALYs) was similar to that of mortality. In NHANES, after adjusting for confounders, HbA1c had independent nonlinear association with increased all-cause mortality in cancer survivors (nonlinear P value = 0.034). The threshold value for HbA1c was 5.4%, and the HRs (95% CI) below and above the threshold value were 0.93 (0.87, 0.99) and 1.03 (1.01, 1.05), respectively.Interpretation: The cancer mortality and DALYs attributed to HFPG have upsurged during the past three decades. In addition, it was found that countries with a higher SDI have a higher age-standardized mortality as well as DALYs, countries with a lower SDI have a larger increase rate. Unfavorable period and cohort effects on mortality and DALYs were seen across almost all countries with different SDI levels. Furthermore, it was suggested that the critical value of HbA1c in decreased mortality was 5.4%, which may prevent premature death in cancer survivors.Funding: This research was funded by the industry prospecting and common key technology key projects of Jiangsu Province Science and Technology Department (Grant no. BE2020721); Nanjing Life and Health Technology Special Project "Cooperative research, development and transformation of active intelligent health management platform for diabetes mellitus" (202205053); the Industrial and Information Industry Transformation and Upgrading Special Fund of Jiangsu Province in 2021 (Grant no. [2021]92)); the Key Project of Smart Jiangsu in 2020 (Grant no. [2021]1); Jiangsu Province Engineering Research Center of Big Data Application in Chronic Disease and Intelligent Health Service (Grant no. [2020]1460).Declaration of Interest: The authors declare that they have no conflict of interest.Ethical Approval: The studies involving human participants were reviewed and approved by the National Center for Health Statistics of the Center for Disease Control and Prevention Institutional Review Board. The patients/participants provided their written informed consent to participate in this study.

Historical trends of breast cancer burden attributable to metabolic factors among Chinese women, 1990–2019: A population‐based epidemiological study

Trends in breast cancer mortality attributable to metabolic risks in Chinese women from 1990 to 2019: an age-period-cohort analysis

Estimation of cancer mortality attributable to excess body weight during 2006-2015 in China

Estimation of Cancer Mortality Attributable to Excess Body Weight During 2006-2015 in China.

Trends of the Burden of Type 2 Diabetes Mellitus Attributable to High Body Mass Index from 1990 to 2019 in China

A Hierarchical Age-Period-Cohort Analysis Of Breast Cancer Mortality And Disability Adjusted Life Years (1990-2015) Attributable To Modified Risk Factors Among Chinese Women

Changes in the disease burden of breast cancer along with attributable risk factors in China from 1990 to 2019 and its projections: An analysis of the global burden of disease study 2019

The Global, Regional, and National Burden and Trends of Breast Cancer From 1990 to 2019: Results From the Global Burden of Disease Study 2019

Effects of reproductive and demographic changes on breast cancer incidence in China: a modeling analysis.

Epidemiological Trends of Female Breast and Gynecologic Cancers in Adolescents and Young Adults in China from 1990 to 2019: Results from the Global Burden of Disease Study 2019.

The temporal trend of disease burden attributable to metabolic risk factors in China, 1990-2019: An analysis of the Global Burden of Disease study

Global, regional, and national mortality trends of female breast cancer by risk factor, 1990-2017

Estimation of Cancer Incidence and Mortality Attributable to Overweight, Obesity, and Physical Inactivity in China.

The Burden and Trends of Breast Cancer from 1990 to 2017 at the Global, Regional, and National Levels: Results from the Global Burden of Disease Study 2017

Global and Regional Trends in Incidence and Mortality of Female Breast Cancer and Associated Factors at National Level in 2000 to 2019

Global, reginal, national burden and risk factors in female breast cancer from 1990 to 2021

Evaluation of lifestyle risk factor differences in global patterns of breast cancer mortality and DALYs during 1990-2017 using hierarchical age-period-cohort analysis

Emerging patterns and trends in global cancer burden attributable to metabolic factors, based on the Global Burden of Disease Study 2019

Trends in disease burden of type 2 diabetes, stroke, and hypertensive heart disease attributable to high BMI in China: 1990–2019

Global, Regional, and National Time Trends in Cancer Burden Attributed to High Fasting Plasma Glucose and the Association Between Glycemic Levels and All-Cause Mortality in Cancer Survivors: an Age-Period Cohort Analysis and A Retrospective Cohort Study

Lifestyle and Socioeconomic Transition and Health Consequences of Breast Cancer in the East Asia Region, from 1990 to 2019